E

ENCell Co Ltd
KOSDAQ:456070

Watchlist Manager
ENCell Co Ltd
KOSDAQ:456070
Watchlist
Price: 14 410 KRW -6.12%
Market Cap: 153.5B KRW
Have any thoughts about
ENCell Co Ltd?
Write Note

ENCell Co Ltd
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

ENCell Co Ltd
Cash & Cash Equivalents Peer Comparison

Comparables:
207940
S
237690
F
220100
L
141080
C
268600

Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
E
ENCell Co Ltd
KOSDAQ:456070
Cash & Cash Equivalents
â‚©18.7B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Samsung Biologics Co Ltd
KRX:207940
Cash & Cash Equivalents
â‚©973.5B
CAGR 3-Years
129%
CAGR 5-Years
147%
CAGR 10-Years
N/A
S
ST Pharm Co Ltd
KOSDAQ:237690
Cash & Cash Equivalents
â‚©50.1B
CAGR 3-Years
22%
CAGR 5-Years
26%
CAGR 10-Years
N/A
F
FutureChem Co Ltd
KOSDAQ:220100
Cash & Cash Equivalents
â‚©5.4B
CAGR 3-Years
20%
CAGR 5-Years
33%
CAGR 10-Years
N/A
L
LegoChem Biosciences Inc
KOSDAQ:141080
Cash & Cash Equivalents
â‚©15.5B
CAGR 3-Years
3%
CAGR 5-Years
18%
CAGR 10-Years
51%
C
Cellivery Therapeutics Inc
KOSDAQ:268600
Cash & Cash Equivalents
â‚©589.8m
CAGR 3-Years
-72%
CAGR 5-Years
-38%
CAGR 10-Years
N/A

See Also

What is ENCell Co Ltd's Cash & Cash Equivalents?
Cash & Cash Equivalents
18.7B KRW

Based on the financial report for Dec 31, 2023, ENCell Co Ltd's Cash & Cash Equivalents amounts to 18.7B KRW.

What is ENCell Co Ltd's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 1Y
-14%

Over the last year, the Cash & Cash Equivalents growth was -14%.

Back to Top